title: Limitations and challenges in treatment of acute chemical warfare agent poisoning.
abstract: Recent news from Syria on a possible use of chemical warfare agents made the headlines. Furthermore, the motivation of terrorists to cause maximal harm shifts these agents into the public focus. For incidents with mass casualties appropriate medical countermeasures must be available. At present, the most important threats arise from nerve agents and sulfur mustard. At first, self-protection and protection of medical units from contamination is of utmost importance. Volatile nerve agent exposure, e.g. sarin, results in fast development of cholinergic crisis. Immediate clinical diagnosis can be confirmed on-site by assessment of acetylcholinesterase activity. Treatment with autoinjectors that are filled with 2mg atropine and an oxime (at present obidoxime, pralidoxime, TMB-4 or HI-6) are not effective against all nerve agents. A more aggressive atropinisation has to be considered and more effective oximes (if possible with a broad spectrum or a combination of different oximes) as well as alternative strategies to cope with high acetylcholine levels at synaptic sites should be developed. A further gap exists for the treatment of patients with sustained cholinergic crisis that has to be expected after exposure to persistent nerve agents, e.g. VX. The requirement for long-lasting artificial ventilation can be reduced with an oxime therapy that is optimized by using the cholinesterase status for guidance or by measures (e.g. scavengers) that are able to reduce the poison load substantially in the patients. For sulfur mustard poisoning no specific antidote is available until now. Symptomatic measures as used for treatment of burns are recommended together with surgical or laser debridement. Thus, huge amounts of resources are expected to be consumed as wound healing is impaired. Possible depots of sulfur mustard in tissues may aggravate the situation. More basic knowledge is necessary to improve substantially therapeutic options. The use of stem cells may provide a new and promising option.
authors.affiliation: Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany. Electronic address: horstthiermann@bundeswehr.org.
authors.forename: Horst
authors.initials: H
authors.lastname: Thiermann
authors.forename: Franz
authors.initials: F
authors.lastname: Worek
authors.forename: Kai
authors.initials: K
authors.lastname: Kehe
mesh_terms: D000931:Antidotes / Q000008:administration & dosage; D001285:Atropine / Q000008:administration & dosage; D002618:Chemical Warfare; D002619:Chemical Warfare Agents / Q000737:chemistry / Q000506:poisoning*; D002800:Cholinesterase Inhibitors / Q000506:poisoning; D003666:Decontamination; D006801:Humans; D009151:Mustard Gas / Q000506:poisoning; D009946:Organothiophosphorus Compounds / Q000506:poisoning; D010091:Oximes / Q000008:administration & dosage; D012524:Sarin / Q000506:poisoning
chemical_list: D000931:Antidotes; D001285:Atropine; D002619:Chemical Warfare Agents; D002800:Cholinesterase Inhibitors; D009151:Mustard Gas; D009946:Organothiophosphorus Compounds; D010091:Oximes; D012524:Sarin; C009680:VX-agent
keywords: Acetylcholinesterase; Chemical warfare agents; Human; Organophosphorus compounds; Sulfur mustard; Treatment